使用iPSCs建模遗传性外围神经病变的进展和挑战
Jonas Van Lent1,2,3,4, Robert Prior5, Gonzalo Pérez Siles6
1Peripheral Neuropathy Research Group, Department of Biomedical Sciences, University of Antwerp, 2610, Antwerp, Belgium.
Experimental & molecular medicine
|June 2, 2024
概括
遗传性外围神经病变 (IPN) 缺乏临床治疗方法. 本综述探讨了先进的人类诱导多能干细胞 (iPSC) 模型,以开发有效的IPN疗法.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 细胞生物学 细胞生物学
背景情况:
- 遗传性外围神经病变 (IPN) 是一种影响外围神经发育和功能的遗传性疾病.
- 分子机制和动物模型的进步尚未为IPNs提供临床治疗.
- 需要更相关的人类模型来研究IPN和开发疗法.
研究的目的:
- 对遗传性外围神经病变的现有体外人类细胞模型进行审查.
- 突出患者特异性诱导多能干细胞 (iPSCs) 的潜力,用于IPN建模.
- 讨论基于iPSC的复杂IPN模型的最新进展.
主要方法:
- 对体外IPN模型的现有文献的审查.
- 专注于2D单种植中的诱导多能干细胞 (iPSC) 衍生物.
- 探索基于iPSC的先进系统,包括微流体芯片,有机体和组合体.
主要成果:
- 在通过细胞和动物模型了解IPN分子机制方面取得了重大进展.
- 患者特定的iPSC为疾病建模和临床前研究提供了一个强大的平台.
- 新兴的复杂iPSC模型 (微流体,有机体,组合体) 提供了更大的生物相关性.
结论:
- 尽管取得了进展,但目前还没有针对IPN的临床治疗方法.
- 来自患者的iPSC模型对于推进IPN研究和治疗开发至关重要.
- 基于iPSC的复杂系统代表了创建用于临床前测试的生物相关IPN模型的下一个前沿.
相关概念视频
01:21EPS and iPS Cells in Disease Research
2.8K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.8K
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:06Induced Pluripotent Stem Cells
4.0K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.0K